You have reached the maximum number of Guideline views for today. By creating a free account, you can increase your number of complimentary daily views.
To view this Guideline, please log in to your account. If you do not have an account, you can create one for free by clicking the button below.
Anaphylaxis
Publication Date: December 17, 2023
Last Updated: October 28, 2024
Diagnosis
Recommendation 1 (CBS)
We recommend obtaining a baseline serum tryptase (bST) in patients presenting with a history of recurrent, idiopathic, or severe anaphylaxis, particularly those presenting with hypotension.
(S, M )
620
Infants and Toddlers
Anaphylaxis in Infants and Toddlers
Recommendation 8 (CBS)
We suggest that clinicians use current NIAID/FAAN or WAO anaphylaxis criteria to assist in the diagnosis of anaphylaxis in infants/toddlers, because there are no criteria specific to this age group.
(C, L )
620
Recommendation 9 (CBS)
We suggest clinicians be aware that, in infants and toddlers, patient age does not correlate with reaction severity.
(C, VL )
620
Recommendation 10 (CBS)
We suggest clinicians be aware that anaphylaxis is unlikely to be the initial reaction to a food or medication on first exposure in infants. (C, L )
620
Recommendation 11 (CBS)
We suggest clinicians be aware that parents of infants and toddlers may report age-specific symptoms that are less often reported by older children and adults.
(C, VL )
620
Recommendation 12 (CBS)
We suggest clinicians prescribe either the 0.1 mg or the 0.15 mg EAI dose for infants/toddlers weighing less than 15 kg.
(C, L )
620
Overview
Title
Anaphylaxis
Authoring Organizations
American College of Allergy, Asthma, and Immunology